Log In
BCIQ
Print this Print this
 

ZPL-868087

  Manage Alerts
Collapse Summary General Information
Company Pfizer Inc.
DescriptionHistamine H3 receptor (HRH3) antagonist
Molecular Target Histamine H3 receptor (HRH3)
Mechanism of ActionHistamine H3 receptor antagonist
Therapeutic Modality 
Latest Stage of DevelopmentPreclinical
Standard IndicationRhinitis
Indication DetailsTreat allergic rhinitis
Regulatory Designation
PartnerZiarco Group Ltd.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

11/12/2012

Undisclosed

0

Undisclosed

Get a free BioCentury trial today